Action Impax labs - IPXLE

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

IMPAX Receives Notice of Delisting from Nasdaq

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that it has received notification from The Nasdaq Stock Market, Inc. that the Nasdaq Listing Qualification Panel has determined to delist...

IMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of Results

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today provided additional information concerning its progress in filing its annual report on Form 10-K for the year ended December 31, 2004 and...

IMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to be

IMPAX Laboratories, Inc. (Nasdaq:IPXLE) today announced that it has entered into a definitive agreement to sell $75 million aggregate principal amount of 3.50% senior subordinated...

IMPAX to Increase Existing Credit Facility

IMPAX Laboratories, Inc. (Nasdaq:IPXLE) announced today that it received commitments from Wachovia Bank, National Association and Wachovia Capital Markets, LLC to increase the Company's...

IMPAX Provides Updates on Progress to File 10-K and Related Matters

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today reported steps taken to complete its financial closing and file its Annual Report on Form 10-K for the year ended December 31, 2004. The Company, in...

CORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20

First graph, first sentence of release should read: xxx a generic version of Rimadyl(R) (Carpofen) 25, 75 and 100 mg Caplets (sted xxx a generic version of Rimadyl(R) (Carpofen) 25, 50 and 75...

IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Animal Drug Application (ANADA...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

IPXLE - Frequently Asked Questions (FAQ)

What is the current Impax labs share price?

The current share price of Impax labs is US$ 0,00

What is the 1 year trading range for Impax labs share price?

Impax labs has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
YIBOPlanet Image International Ltd	US$ 9,33 (333,95%)	17,28M
HWHHWH International Inc	US$ 0,778 (170,42%)	299,44M
JGAurora Mobile Ltd	US$ 13,6635 (127,27%)	24,17M
AKROAkero Therapeutics Inc	US$ 51,29 (95,91%)	10,29M
TOIIWOncology Institute Inc	US$ 0,041 (83,86%)	202,68k
ALLKAllakos Inc	US$ 0,25775 (-78,70%)	26,88M
NXUNXU Inc	US$ 0,297076 (-51,77%)	5,51M
VERUVeru Inc	US$ 0,6402 (-47,09%)	29,96M
WOKWORK Medical Technology Group Ltd	US$ 2,805 (-41,80%)	650,56k
NBISNebius Group NV	US$ 27,39 (-34,30%)	24,94M
NVDANVIDIA Corporation	US$ 118,5901 (-16,85%)	380,18M
HWHHWH International Inc	US$ 0,778 (170,42%)	299,44M
ONCOOnconetix Inc	US$ 0,7297 (52,02%)	172,04M
HOLOMicroCloud Hologram Inc	US$ 1,8096 (16,75%)	163,63M
RGTIRigetti Computing Inc	US$ 12,16 (-7,88%)	86,4M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Impax Laboratories (MM) (IPXLE)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

IPXLE Dernières nouvelles

IMPAX Receives Notice of Delisting from Nasdaq

IMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of Results

IMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to be

IMPAX to Increase Existing Credit Facility

IMPAX Provides Updates on Progress to File 10-K and Related Matters

CORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20

IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005

IPXLE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Impax Laboratories (MM) (IPXLE) Cours

Impax Laboratories (MM) (IPXLE)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

IPXLE Dernières nouvelles

IMPAX Receives Notice of Delisting from Nasdaq

IMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of Results

IMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to be

IMPAX to Increase Existing Credit Facility

IMPAX Provides Updates on Progress to File 10-K and Related Matters

CORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20

IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005

IPXLE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE